πŸ‡ΊπŸ‡Έ FDA
Patent

US 8242137

Crystalline forms of a biphenyl compound

granted A61KA61K31/13A61K31/4545

Quick answer

US patent 8242137 (Crystalline forms of a biphenyl compound) held by Theravance, Inc. expires Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Aug 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/13, A61K31/4545, A61K31/56, A61K31/58